| Mrs Lydia Mckay Arndt, MS, CCC-SLP | |
|
2660 10th Ave S Ste 201, Birmingham, AL 35205-1623 | |
| (205) 933-9036 | |
| (205) 933-9051 |
| Full Name | Mrs Lydia Mckay Arndt |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2660 10th Ave S Ste 201, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215199864 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2732 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lydia Mckay Arndt, MS, CCC-SLP 2660 10th Ave S Ste 201, Birmingham, AL 35205-1623 Ph: (205) 933-9036 | Mrs Lydia Mckay Arndt, MS, CCC-SLP 2660 10th Ave S Ste 201, Birmingham, AL 35205-1623 Ph: (205) 933-9036 |
News Archive
Administration officials and consumer advocates say that the enrollment website serving residents of 36 states is becoming easier for people to use, but insurers warn that flaws continue to hinder health plans. Officials acknowledge that some users will continue to experience outages and error messages. Meanwhile, Bloomberg looks at the president's efforts to monitor the situation.
In a previous study, rheumatoid arthritis (RA) patients who failed to respond to methotrexate were shown to experience positive results with fostamatinib disodium (R788), an oral spleen tyrosine kinase (Syk) inhibitor that is thought to block immune cell signaling involved with bone and cartilage destruction. In the current study, RA patients who failed to respond to biologic agents were studied.
University of British Columbia researchers have led an international team in developing a new test to better diagnose different types of ovarian cancer, a tool that could one day guide and improve treatment options for women diagnosed with the most common and deadliest form of the disease.
A new artificial model of premature infants will make possible experiments that are expected to reduce injury to infants on respirators.
GE Healthcare will introduce several new technologies that demonstrate its ongoing commitment to improving the quality of patient care at ANESTHESIOLOGY 2013, the annual meeting of the American Society of Anesthesiologists, taking place October 12-16 in San Francisco.
› Verified 7 days ago
Ms. Lynn Gazaway Roebuck, M. S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3939 | |
Katherine Seal, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3944 Fax: 205-413-4914 | |
Mrs. Gina Marino Salvagio, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1521 Woodridge Place, Birmingham, AL 35216 Phone: 205-567-2201 Fax: 205-823-6554 | |
Angie Smith Pruett, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2970 Lorna Rd, Birmingham, AL 35216 Phone: 205-981-8900 | |
Ms. Jacquelynn Adams-carr, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 530 Beacon Parkway West, Birmingham, AL 35209 Phone: 205-253-0098 Fax: 205-854-1953 | |
Rebekah Patterson Waldrum, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3921 Fax: 205-413-4914 | |
Lauranne Krepps, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 419 Broadway St, Birmingham, AL 35209 Phone: 407-756-9469 |